最近浏览

实时行情

意见反馈

礼来制药

NYSE:LLY 延时15分钟
  • 今开：--
    昨收：--
  • 今日区间：--
    52周区间：--
  • 成交量：--
    成交额：--
  • 市 值：--
    市盈率：--
  • 贝塔系数：
    每股收益：
成交量

董事会

David A. Ricks
David A. Ricks currently works at Eli Lilly & Co., as Chairman, President & Chief Executive Officer from 2017, Eli Lilly & Co. Ltd., as Chairman & Chief Executive Officer, Eli Lilly Italia SpA, as Chairman & Chief Executive Officer, James Whitcomb Riley Children's Foundation, as Chairman-Governors Board, Adobe, Inc., as Independent Director, Pharmaceutical Research & Manufacturers of America, as Director from 2022, The Central Indiana Corporate Partnership, as Director, The Business Roundtable, as Member, and The Business Council, as Member. Mr. Ricks also formerly worked at European Federation of Pharmaceutical Industries & Assns, as Director, Elanco Animal Health, Inc., as Director from 2018 to 2019, HP, Inc., as Principal, International Business Machines Corp., as Principal, International Federation of Pharmaceutical Manufacturers, as President, Lilly USA LLC, as President from 2009 to 2012, Lilly Industries Shanghai Ltd., as President & General Manager in 2009, and Eli Lilly Canada, Inc., as General Manager from 2005 to 2008. Mr. Ricks received his Masters Business Admin degree in 1996 from Indiana University and undergraduate degree in 1990 from Purdue University.
Jon Erik Fyrwald
Jon Erik Fyrwald is Chief Executive Officer & Director at International Flavors & Fragrances, Inc. since 2024. Holds CEO roles at Syngenta Crop Protection . Solu es Para A Agricultura, Ltda., Syngenta Foundation For Sustainable Agriculture (Chairman & CEO), Syngenta Bangladesh Ltd. (CEO & Director), and Syngenta International AG (CEO & Director since 2016). Chairman of ADAMA Ltd. since 2020. Independent Director at Eli Lilly & Co. since 2005. Director at Biotechnology Innovation Organization, Syngenta AG, ADAMA Agricultural Solutions Ltd. (since 2022), Society of Chemical Industry, The Chicago Public Education Fund, CropLife International, Syngenta Crop Protection AG (since 2023), Syngenta Group Co., Ltd. (since 2023), and Trustee at The Field Museum of Natural History since 2010. Former roles include Chairman, President & CEO at Nalco Co. and Nalco Holding Co. (2008 2011), President & CEO at Univar NV, Univar Solutions UK Ltd., Univar Solutions USA, Inc. (Illinois), and Univar Solutions, Inc. (2012 2016). Chairman at Sinofert Holdings Ltd. (2020 2023). Chairman-Management & Member-Management Director at Syngenta AG. Independent Director at Bunge Ltd. (2018 2023). Group VP-Agriculture & Nutrition Division at EIDP, Inc. (2003 2008). President at Ecolab, Inc. (2011 2012). Director roles at Amsted Industries, Inc., 8th Continent LLC, American Chemistry Council, Inc., Edmundson Art Foundation, Inc., United Way of Central Iowa, World Food Programme, and Swiss-American Chamber of Commerce. Education includes an undergraduate degree from the University of Delaware, conferred in 1981.
Ralph Alvarez
Mr. Ralph Alvarez is a Lead Independent Director at Traeger, Inc., an Independent Chairman at First Watch Restaurant Group, Inc., an Independent Director at Lowe's Companies, Inc., an Independent Director at Eli Lilly & Co. and a Member-Presidents Council at University of Miami School of Business. He is on the Board of Directors at Traeger, Inc., Lowe's Companies, Inc. and Eli Lilly & Co. Mr. Alvarez was previously employed as an Independent Director by Realogy Holdings Corp. (NJ), an Executive Chairman by Skylark Co. Ltd. /Old/, a Chairman by Skylark Co., Ltd., a Lead Independent Director by Dunkin' Brands Group, Inc., a President by McDonald s North America, a President by McDonald's Mexico, a COO & President-Central Division by McDonald's USA LLC, a Regional Director by Chipotle Mexican Grill, Inc., a President, Chief Operating Officer & Director by McDonald's Corp., a Vice President by Wendy s International, Inc., a Budget Analyst by Burger King Corp., a Partner by Advent International LP, a Managing Director by Burger King Espa a SL, a President by Burger King Restaurants of Canada, Inc., a President by Ronald McDonald House Charities Central West, and a Trustee by The Field Museum of Natural History. He also served on the board at Anywhere Real Estate Group LLC, Dunkin' Brands, Inc., KeyCorp, Fox Cities Performing Arts Center, Inc., National Retail Federation, Inc. and The Presidents Council. He received his undergraduate degree from the University of Miami.
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
Katherine Baicker
Katherine Baicker is currently an Independent Director at Eli Lilly & Co., a Trustee at Mayo Clinic, a Member of the Council on Foreign Relations, American Academy of Arts & Sciences, National Academy of Medicine, National Bureau of Economic Research, The Chicago Council on Global Affairs, National Opinion Research Center, and National Academy of Social Insurance. She is also the Dean & Professor at The University of Chicago Harris School of Public Policy and the Dean at Harris School of Public Policy Studies. Her former jobs include Chairman-Social Sciences & Population Study at National Institutes of Health, Vice Chairman at AcademyHealth, Chairman at The Group Insurance Commission, Independent Director at HMS Holdings Corp., Associate Professor & Assistant Professor at Dartmouth College, Member of Council of Economic Advisers, and Professor-Health Economics at Harvard T.H. Chan School of Public Health. She is also a former Trustee at The Urban Institute and a Member-Editorial Board at Health Affairs. Baicker received her doctorate from Harvard University and her undergraduate degree from Yale University.
David A. Ricks
David A. Ricks currently works at Eli Lilly & Co., as Chairman, President & Chief Executive Officer from 2017, Eli Lilly & Co. Ltd., as Chairman & Chief Executive Officer, Eli Lilly Italia SpA, as Chairman & Chief Executive Officer, James Whitcomb Riley Children's Foundation, as Chairman-Governors Board, Adobe, Inc., as Independent Director, Pharmaceutical Research & Manufacturers of America, as Director from 2022, The Central Indiana Corporate Partnership, as Director, The Business Roundtable, as Member, and The Business Council, as Member. Mr. Ricks also formerly worked at European Federation of Pharmaceutical Industries & Assns, as Director, Elanco Animal Health, Inc., as Director from 2018 to 2019, HP, Inc., as Principal, International Business Machines Corp., as Principal, International Federation of Pharmaceutical Manufacturers, as President, Lilly USA LLC, as President from 2009 to 2012, Lilly Industries Shanghai Ltd., as President & General Manager in 2009, and Eli Lilly Canada, Inc., as General Manager from 2005 to 2008. Mr. Ricks received his Masters Business Admin degree in 1996 from Indiana University and undergraduate degree in 1990 from Purdue University.
William G. Kaelin
William G. Kaelin is the founder of Tango Therapeutics Sub, Inc. (founded in 2017), Cedilla Therapeutics, Inc. (founded in 2017), and Tango Therapeutics, Inc. (founded in 2017). Current jobs include Independent Director at Eli Lilly & Co. since 2012, Director at The Damon Runyon Cancer Research Foundation, Director at LifeMine Therapeutics, Inc. since 2021, Director at IconOVir Bio, Inc. since 2022, Independent Director at IQVIA Holdings, Inc. starting 2025, Trustee at Duke University, Professor at Dana-Farber Cancer Institute, Inc., Professor at The Brigham & Women's Hospital, Inc. since 2002, Member of the National Academy of Sciences, Member of the American Academy of Arts & Sciences, Member of the Association of American Physicians, Member of Dana-Farber, Member of the American Society of Clinical Investigation, Professor at Harvard Medical School since 2002, and Advisor at Casdin Capital. Former jobs include Chief Resident & House Officer at The Johns Hopkins Hospital, Inc., Member-Advisory Board at National Cancer Institute, Member of the National Academy of Medicine (United States), Member of the American College of Physicians, Inc., and Trustee of the American Association for Cancer Research. Education includes undergraduate degree from Duke University in 1982 and a doctorate from Duke University School of Medicine.
Juan Ricardo Luciano
Juan Ricardo Luciano is currently the Chairman, President & Chief Executive Officer at Archer-Daniels-Midland Co. He is also the Lead Independent Director at Eli Lilly & Co. Additionally, he holds director positions at Rush System for Health, The Business Council, ADM Grain River System, Inc., ADM Clinton BioProcessing, Inc., Intersect Illinois, The Commercial Club of Chicago, The Business Roundtable, Dow Hydrocarbons & Resources LLC, Global Advisory Board, and The Economic Club of Chicago. In the past, Mr. Luciano served as a Director at ADM Alliance Nutrition, Inc. and as a Non-Executive Director at Wilmar International Ltd. He also held director positions at The Economic Club of Chicago (Illinois), Kellogg School of Management, and The Dow Chemical Co., where he was the President-Performance Division. Furthermore, he served as a Trustee at Boys & Girls Clubs of America and Rush University Medical Center, and as a Member of the US-China Business Council. Mr. Luciano completed his undergraduate degree at Instituto Tecnol gico de Buenos Aires.
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
Jamere Jackson
Jamere Jackson is currently an Independent Director at Eli Lilly & Co. since 2016, a Director at Azaa Investments, Inc., Youth Villages, Inc., and Future 5, and the Chief Financial Officer at AutoZone, Inc. since 2023. Former positions include Independent Director at Hibbett, Inc. from 2020 to 2022; Chief Financial Officer and Executive Vice President at The Hertz Corp. and Hertz Global Holdings, Inc. from 2018 to 2020; Chief Financial Officer at Nielsen Holdings Ltd. from 2014 to 2018; VP, Chief Financial Officer-Drilling & Surface at Baker Hughes Energy Services LLC from 2013 to 2014; Senior Executive-Finance at GE Aviation Systems LLC from 2007 to 2013; Principal at GE Aerospace from 2004 to 2014; and Principal roles at First Data Corp., Procter & Gamble Co., Total System Services LLC, Yum! Brands, Inc., and The Nielsen Company (US) LLC. Other former roles include Chief Financial Officer at Nielsen NV and. The Nielsen Co. BV, Treasurer at Unison Industries LLC. Education includes an undergraduate degree from the University of Notre Dame, conferred in 1990.
Gabrielle G. Greene-Sulzberger
Gabrielle G. Greene-Sulzberger founded Fontis Partners LP in 2009, where she worked as General Partner from 2009 to 2017. Ms. Greene-Sulzberger also currently works at Sesame Workshop, as Chairman, True Food Kitchen Investco LLC, as Chairman from 2019, auxmoney GmbH, as Chairman, and various other companies. Ms. Greene-Sulzberger also formerly worked at Johnson Products Co., Inc., as Chief Executive Officer from 2011 to 2013, Teneo Holdings LLC, as Chairman-ESG Practice, Teneo Consulting LLC, as Chairman-ESG Practice, and various other companies. Ms. Greene-Sulzberger received her Masters Business Admin degree in 1987 from Harvard Business School, graduate degree from Harvard Law School, and undergraduate degree from Woodrow Wilson School of Public & International Affairs.
Kimberly H. Johnson
Kimberly H. Johnson currently works at Eli Lilly & Co., as Independent Director from 2021, Greater Washington Board of Trade, as Director, Share Our Strength, Inc., as Director, Calvert Impact Capital, Inc., as Director, After-School All-Stars, as Director, Planet Works, Inc., as Director, Communities In Schools of The Nations Capital, as Director, T. Rowe Price Group, Inc., as Chief Operating Officer from 2022, and Princeton University, as Trustee. Ms. Johnson also formerly worked at Credit Suisse Group AG, as Director, Credit Suisse (USA) LLC, as Director, Federal National Mortgage Association, as Chief Operating Officer & Executive Vice President from 2018 to 2022, and D.E. Shaw & Co. LLC, as Equity Trader. Ms. Johnson received her undergraduate degree from Princeton University and Masters Business Admin degree from Columbia Business School.
Mary Lynne Hedley
Mary Lynne Hedley founded Zycos, Inc. in 1996, where she worked as President & Chief Executive Officer from 1996 to 2004 and Tesaro, Inc. in 2010, where she is working as President & Director. Dr. Hedley also currently works at Eli Lilly & Co., as Independent Director from 2022, Veeva Systems, Inc., as Independent Director from 2019, Millendo Therapeutics US, Inc., as Director from 2017, Helsinn Holding SA, as Director from 2021, Youville Place, as Director, Centessa Pharmaceuticals Plc, as Independent Non-Executive Director from 2021, Women Innovating Together In Healthcare, as Director, Youville Assisted Living Residences, as Director, Third Rock Ventures LLC, as Venture Partner from 2023, The American Association of Immunologists, as Member, American Association for the Advancement of Science, as Member, American Society of Clinical Oncology, Inc., as Member, and The American Association of Cancer Research, as Member. Dr. Hedley also formerly worked at Receptos LLC, as Independent Director from 2014 to 2015, bluebird bio, Inc., as Independent Director from 2017 to 2019, Millendo Therapeutics, Inc., as Independent Director from 2017 to 2021, Helsinn Healthcare SA, as Director from 2021 to 2023, MGI PHARMA, Inc., as Chief Scientific Officer & Executive VP from 2004 to 2008, Abraxis BioScience, Inc., as Chief Scientific Officer & EVP-Operations from 2009 to 2010, Eisai Corp. of North America, as Executive Vice President from 2008 to 2009, and MGI PHARMA Biologics, Inc., as General Manager & Senior Vice President. Dr. Hedley received her undergraduate degree in 1983 from Purdue University and doctorate degree in 1988 from The University of Texas Southwestern Medical Center.
Jon R. Moeller
Jon R. Moeller currently works at Procter & Gamble Co., as Chairman, President & Chief Executive Officer from 2022, Procter & Gamble Service GmbH, as Chairman, President & Chief Executive Officer, Procter & Gamble (Manufacturing) Ireland Ltd., as Chief Operating Officer, CFO & Vice Chairman, MDVIP LLC (Florida), as Director, Natura Pet Products, Inc., as Director, The Consumer Goods Forum, as Director, Isle of Harris Distillers Ltd., as Director, Alliance To End Plastic Waste, as Director, The Business Roundtable, as Director, Eli Lilly & Co., as Director from 2024, Commercial Club of Cincinnati, as Trustee, Cincinnati Art Museum, as Vice President, and The Conference Board Council of Financial Executives, as Member. Mr. Moeller also formerly worked at Monsanto Co., as Independent Director from 2011 to 2018 and Visiting Nurse Association, as Trustee. Mr. Moeller received his undergraduate degree in 1986 and Masters Business Admin degree in 1988 from Cornell University.
Carolyn R. Bertozzi
Carolyn R. Bertozzi founded Redwood Bioscience, Inc. in 2008, Palleon Pharmaceuticals, Inc. in 2015, Venn Biosciences Corp. in 2017, and Lycia Therapeutics, Inc. in 2019. Dr. Bertozzi also founded Firefly Bio, Inc. and Enable Biosciences, Inc., where she is working as Chairman. Dr. Bertozzi also currently works at Grace Science Foundation, as Director, OmniAb Operations, Inc., as Independent Director, OmniAb, Inc., as Independent Director from 2022, Stanford Chem-H, as Director from 2021, Xaira Therapeutics, Inc., as Director, Eli Lilly & Co., as Director from 2025, Stanford University, as Professor, American Chemical Society, as Member, The Royal Society, as Member, Howard Hughes Medical Institute, Inc., as Professor, National Academy of Sciences, as Member, American Academy of Arts & Sciences, as Member, National Academy of Medicine (United States), as Member, American Society for Biochemistry & Molecular Biology, Inc., as Member, Accademia Nazionale dei Lincei, as Member, and National Academy of Inventors, as Member. Dr. Bertozzi also formerly worked at Eli Lilly & Co., as Independent Director from 2017 to 2021, Lawrence Berkeley National Laboratory, as Director-Molecular Foundry, The Broad Institute, Inc., as Director, Catalent, Inc., as Director, Molecular Foundry, as Director, Alnylam Pharmaceuticals, Inc., as Independent Director from 2023 to 2025, and the University of California, Berkeley, as Professor from 1996 to 2015. Dr. Bertozzi received her undergraduate degree in 1988 from Harvard University and doctorate degree in 1993 from the University of California, Berkeley.